Literature DB >> 12417353

Similarities between Alzheimer's disease and vascular dementia.

Raj Kalaria1.   

Abstract

Alzheimer's disease (AD) and vascular dementia (VaD) are the two most common forms of dementia. In Europe, 800,000 people have a diagnosis of VaD out of 3.7 million people with clinical dementia. These two dementia types share many common pathological, symptomatic and neurochemical features, and cholinergic treatments that have demonstrated robust, broad-ranging and long-term efficacy in AD are now being assessed for the treatment of dementia related to cerebrovascular disease (CVD). There has been recent recognition that dementia in the elderly is a continuum of pathologies, with pure AD and VaD representing the two extremes, and 'mixed' dementia (AD with CVD) in between and perhaps comprising the majority of cases. 'Mixed' dementia is rarely diagnosed in the clinic, however, as the majority of diagnostic procedures are biased toward a diagnosis of AD. Here, the risk factors, pathophysiological mechanisms and clinical symptoms of AD and VaD are described, identifying their overlap as well as some of the differences in both cognitive and noncognitive symptoms. Important findings indicating the high prevalence of 'mixed' dementia in the clinical dementia population are also discussed. In particular, evidence of a causal connection between stroke or CVD and AD is addressed. Regarding effective therapeutic management of dementia patients, further concerted epidemiological study of these related dementia types should aid in clinical decisions on the applicability of cholinergic treatments.

Entities:  

Mesh:

Year:  2002        PMID: 12417353     DOI: 10.1016/s0022-510x(02)00256-3

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  44 in total

1.  Diagnosis of suspected Alzheimer's disease is improved by automated analysis of regional cerebral blood flow.

Authors:  Bich-Ngoc-Thanh Tang; Satoshi Minoshima; Jean George; Annie Robert; Christian Swine; Patrice Laloux; Thierry Vander Borght
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-07-01       Impact factor: 9.236

Review 2.  Vascular aspects of cognitive impairment and dementia.

Authors:  Maximilian Wiesmann; Amanda J Kiliaan; Jurgen A H R Claassen
Journal:  J Cereb Blood Flow Metab       Date:  2013-09-11       Impact factor: 6.200

3.  The 894G > T (Glu298Asp) variant in the endothelial NOS gene and MTHFR polymorphisms influence homocysteine levels in patients with cognitive decline.

Authors:  Nadia Ferlazzo; Gaetano Gorgone; Daniela Caccamo; Monica Currò; Salvatore Condello; Francesco Pisani; Fabrizio Vernieri; Paolo Maria Rossini; Riccardo Ientile
Journal:  Neuromolecular Med       Date:  2011-05-24       Impact factor: 3.843

4.  A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology.

Authors:  Michael L Alosco; Michael A Sugarman; Lilah M Besser; Yorghos Tripodis; Brett Martin; Joseph N Palmisano; Neil W Kowall; Rhoda Au; Jesse Mez; Charles DeCarli; Thor D Stein; Ann C McKee; Ronald J Killiany; Robert A Stern
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

5.  Alzheimer's disease and disseminated mycoses.

Authors:  R Alonso; D Pisa; A Rábano; L Carrasco
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-01-23       Impact factor: 3.267

6.  A Network Pharmacology-Based Analysis of Multi-Target, Multi-Pathway, Multi-Compound Treatment for Ovarian Serous Cystadenocarcinoma.

Authors:  Dan-Dan Xiong; Yue Qin; Wen-Qing Xu; Rong-Quan He; Hua-Yu Wu; Dan-Min Wei; Jing-Jing Zeng; Yi-Wu Dang; Gang Chen
Journal:  Clin Drug Investig       Date:  2018-10       Impact factor: 2.859

7.  The role of the -427T/C apolipoprotein E promoter polymorphism in the pathogenesis of Alzheimer's disease, vascular dementia and mixed dementia.

Authors:  Marianna Trebunová; Eva Slabá; Viera Habalová; Zuzana Gdovinová
Journal:  J Neural Transm (Vienna)       Date:  2009-01-14       Impact factor: 3.575

8.  Network-based elucidation of human disease similarities reveals common functional modules enriched for pluripotent drug targets.

Authors:  Silpa Suthram; Joel T Dudley; Annie P Chiang; Rong Chen; Trevor J Hastie; Atul J Butte
Journal:  PLoS Comput Biol       Date:  2010-02-05       Impact factor: 4.475

Review 9.  Inflammation in central nervous system injury.

Authors:  Stuart M Allan; Nancy J Rothwell
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2003-10-29       Impact factor: 6.237

10.  Quantification of myelin loss in frontal lobe white matter in vascular dementia, Alzheimer's disease, and dementia with Lewy bodies.

Authors:  Masafumi Ihara; Tuomo M Polvikoski; Ros Hall; Janet Y Slade; Robert H Perry; Arthur E Oakley; Elisabet Englund; John T O'Brien; Paul G Ince; Raj N Kalaria
Journal:  Acta Neuropathol       Date:  2010-01-21       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.